Related Experiment Video
Updated: Jun 18, 2026
07:08
A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
[Evaluation and maintenance of heart donors]
R Hinojosa1, A Herruzo, A M Escoresca Ortega
1Servicio de Cuidados Críticos y Urgencias, Hospital Universitario Virgen del Rocío, Seville, Spain. rafahino3@yahoo.es
Medicina Intensiva
|November 17, 2009
Summary
Donor scarcity limits heart transplantation for end-stage heart failure. Strategies like optimizing donor selection, expanding criteria, and improving organ maintenance are crucial to increase transplant rates.
Area of Science:
- Cardiology
- Transplantation Medicine
- Organ Donation
Context:
- Heart transplantation is the optimal treatment for end-stage heart failure refractory to conventional therapies.
- A significant disparity exists between the demand for and supply of donor hearts, limiting transplant numbers.
Purpose:
- To outline strategies for increasing heart transplantation rates.
- To address the critical issue of donor organ scarcity in heart transplantation.
Summary:
- Effective strategies are needed to bridge the gap between donor organ supply and patient demand.
- Key strategies include optimizing donor selection, expanding eligibility criteria for donors, and improving the physiological maintenance of procured organs.
- Future advancements like hormone replacement therapy and genomic evaluation may further enhance outcomes.
Impact:
- Increased heart transplant rates are anticipated through improved donor utilization and organ preservation.
- Enhanced donor management and recipient prognoses will be facilitated by these proposed strategies.
- These advancements aim to improve the quality of life and survival for patients with terminal heart failure.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...